Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2011 May 5;81(3):e101–e109. doi: 10.1016/j.ijrobp.2011.01.013

Table 7.

Unadjusted Proportional Hazards Regression Models for Local-Regional Failure

Primary Site (Others vs. Oropharynx [RL1]) T-Stage (T4 vs. T1-3 [RL1])

Treatment Arm Unadjusted Hazard Ratio (95% CI1) p-value Unadjusted Hazard Ratio (95% CI1) p-value
9003: Arm 1 – SFX 1.27 (0.94, 1.72) 0.11 2.04 (1.50, 2.78) <0.0001
9003: Arm 2 – HFX 1.00 (0.71, 1.40) 0.99 2.46 (1.76, 3.44) <0.0001
9003: Arm 3 – AHFX-S 1.09 (0.80, 1.49) 0.59 1.88 (1.37, 2.59) 0.0001
9003: Arm 4 – AFX-C 1.14 (0.81, 1.59) 0.45 2.12 (1.52, 2.95) <0.0001
9111: Arm 1 – I+RT -- -- 0.35 (0.11, 1.16) 0.09
9111: Arm 2 – CRT -- -- 1.26 (0.52, 3.02) 0.61
9111: Arm 3 – RT Alone -- -- 1.51 (0.70, 3.25) 0.29
9703: Arm 1 – Cispl/5-FU 1.40 (0.75, 2.60) 0.29 1.97 (1.06, 3.68) 0.03
9703: Arm 2 – Hydroxy/5-FU 0.96 (0.51, 1.78) 0.89 2.16 (1.17, 3.97) 0.01
9703: Arm 3 – Cispl/Taxol 1.43 (0.72, 2.87) 0.31 2.59 (1.31, 5.12) 0.007

Chi Square T.S. (Q) = 2.325 Chi Square T.S. (Q) = 11.944
p-value = 0.20 p-value = 0.96

Pooled HR2 1.14 (0.99, 1.33) -- 2.02 (1.75, 2.33) --
1

CI = Confidence Interval; RL = Reference Level

2

This is a pooled estimate.